Failure of Erythromycin to Cure Secondary Syphilis in a Patient Infected with the Human Immunodeficiency Virus

Overview

Journal Arch Dermatol

Specialty Dermatology

Date 1989 Jan 1

PMID 2910209

Citations 4

Authors

W C Duncan

Affiliations

Soon will be listed here.

Abstract

The case presented here involves a 32-year-old homosexual man with human immunodeficiency virus seropositivity and secondary syphilis. Because of possible penicillin allergy, he was initially treated with erythromycin base by mouth. During four weeks of therapy, his cutaneous lesions worsened as did his systemic symptoms. Following desensitization and parenteral penicillin therapy, his cutaneous lesions and symptoms rapidly resolved. His VDRL titer fell appropriately.

Citing Articles

Macrolide Resistance in the Syphilis Spirochete, Treponema pallidum ssp. pallidum: Can We Also Expect Macrolide-Resistant Yaws Strains?.

Smajs D, Pastekova L, Grillova L Am J Trop Med Hyg. 2015; 93(4):678-83.

PMID: 26217043 PMC: 4596581. DOI: 10.4269/ajtmh.15-0316.

[Syphilis treatment. German and international guidelines--a comparison].

Schofer H Hautarzt. 2004; 56(2):141-50.

PMID: 15619079 DOI: 10.1007/s00105-004-0870-9.

Syphilis in pregnancy.

Genc M, Ledger W Sex Transm Infect. 2000; 76(2):73-9.

PMID: 10858706 PMC: 1758294. DOI: 10.1136/sti.76.2.73.

A point mutation associated with bacterial macrolide resistance is present in both 23S rRNA genes of an erythromycin-resistant Treponema pallidum clinical isolate.

Stamm L, Bergen H Antimicrob Agents Chemother. 2001; 44(3):806-7.

PMID: 10755994 PMC: 89774. DOI: 10.1128/AAC.44.3.806-807.2000.